ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ELYM Eliem Therapeutics Inc

10.05
1.66 (19.79%)
May 03 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -10.7M-13.13M-13.7M-8.75M-9.55M-23.44M-6.71M-5M
Pre Tax Income -10.55M-13.2M-14.6M-9.68M-7.76M-22.29M-5.22M-3.97M
Net Income -15.09M-13.2M-14.6M-9.68M-7.76M-22.29M-5.22M-3.97M
Preferred Dividends -4.55M0000000
Basic Earnings Per Share (EPS) 00000000
EBIT -10.62M-13.05M-13.55M-8.37M-9.55M-23.44M-6.71M-1.73M
EBITDA -10.7M-13.13M-13.7M-8.75M-9.55M-23.44M-6.71M-5M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -35.67M-45.14M-40.28M
Pre Tax Income -47.48M-45.24M-35.12M
Net Income -52.03M-45.24M-35.12M
Preferred Dividends -4.55M00
Basic Earnings Per Share (EPS) -1.983-1.703-1.279
EBIT -47.31M-45.14M-40.28M
EBITDA -35.67M-45.14M-40.28M

Your Recent History

Delayed Upgrade Clock